New Era for Novel CNS Drug Development
Author:
Publisher
Springer Science and Business Media LLC
Subject
Psychiatry and Mental health,Pharmacology
Link
http://www.nature.com/articles/npp2011186.pdf
Reference5 articles.
1. Borsook D, Hargreaves RJ, Becerra L (2011). Can functional magnetic resonance imaging improve success rates in central nervous system drug discovery? Expert Opin Drug Discov 6: 598–617.
2. Hessa A, Axmannb R, Rechb J, Finzelb S, Heindla C, Kreitza S et al. (2011). Blockade of TNF-α rapidly inhibits pain responses in the central nervous system. PNAS 108: 3731–3736.
3. Keller M, Montgomery S, Ball W, Morrison M, Snavely D, Liu G et al. (2006). Lack of efficacy of the substance p (neurokinin1 receptor) antagonist aprepitant in the treatment of major depressive disorder. Biol Psychiatry 59: 216–223.
4. Paul SM, Mytelka DS, Dunwiddie CT, Persinger CC, Munos BH, Lindborg ST et al. (2010). How to improve R&D productivity: the pharmaceutical industry's grand challenge. Nat Rev Drug Discov 9: 204–214.
5. Pinard E, Alanine A, Alberati D, Bender M, Borroni E, Brom V et al. (2010). Selective GlyT1 inhibitors: discovery of [4-(3-fluoro-5-trifluoromethylpyridin-2-yl)piperazin-1-yl][5-methanesulfonyl-2-((S)-2,2,2-trifluoro-1-methylethoxy)phenyl]methanone (RG1678), a promising novel medicine to treat schizophrenia. J Med Chem 53: 4603–4614.
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Benefits of curcumin in brain disorders;BioFactors;2019-06-11
2. Experimental Medicine Approaches in CNS Drug Development;Translational Medicine in CNS Drug Development;2019
3. Intranasal administration of pullulan-based nanoparticles for enhanced delivery of adriamycin into the brain: in vitro and in vivo evaluation;PHARMAZIE;2019
4. Brain activity patterns in high-throughput electrophysiology screen predict both drug efficacies and side effects;Nature Communications;2018-01-15
5. Medications for substance use disorders (SUD): emerging approaches;Expert Opinion on Emerging Drugs;2017-10-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3